TRIM39 and inflammatory bowel disease: By using a high-throughput DNA methylation method to detect peripheral blood mononuclear cells of IBD patients, a previous study has shown that there is an IBD-related differentially methylated region (DMR) in the TRIM39-RPP2 promoter region, which is proved to be hypomethylated in the colon of pediatric UC patients.